SCHEMBL764319

SCHEMBL764319

Cc1ccc(-c2ccoc2)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.56
CYP11B2 P19099 2/20 0.56
CCR1 P32246 1/20 0.56
CCR5 P51681 1/20 0.56
CCR8 P51685 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
CYP3A4 P08684 2/20 0.49
CYP2A6 P11509 1/20 0.49
METAP2 P50579 1/20 0.42
FYN P06241 4/20 0.40
PIM1 P11309 1/20 0.40
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 3/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
USP2 O75604 2/20 0.39
CYP2D6 P10635 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567008 0.87 CYP11B1 (0.49) CYP11B1CYP11B2CCR1CCR5CCR8
SCHEMBL852125 0.77 FYN (0.46) CYP11B1CYP11B2FYNPIM1ALDH1A1
SCHEMBL7945635 0.77 CYP1A2 (0.51) CYP11B1CYP11B2CYP3A4FYNPIM1
SCHEMBL17051514 0.77 CCR1 (0.75) CYP11B1CYP11B2CCR1CCR5CCR8
SCHEMBL10331373 0.77 CYP11B1 (0.46) CYP11B1CYP11B2FYNPIM1ALDH1A1
SCHEMBL12924502 0.77 CYP11B1 (0.46) CYP11B1CYP11B2CYP3A4FYNPIM1
SCHEMBL2716514 0.77 CYP11B1 (0.49) CYP11B1CYP11B2CYP3A4FYNPIM1
SCHEMBL2716516 0.77 CYP11B1 (0.59) CYP11B1CYP11B2CYP3A4FYNPIM1
SCHEMBL2477927 0.74 CCR1 (0.71) CCR1CCR5CCR8HDAC6CYP3A4
SCHEMBL13483666 0.74 CCR1 (0.71) CYP11B1CYP11B2CCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
EP-2078015-B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1 AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed
WO-2008057859-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-I AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-15 WO disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed